August 20, 2021 – Johnson & Johnson (New Brunswick, NJ) announced that Alex Gorsky, chairman and CEO, will serve as executive chairman of Johnson & Johnson and transition the CEO role to Joaquin Duato, currently vice chairman of the company’s executive committee, effective January 3, 2022.
Following the transition of the CEO role, Duato will also be appointed as a member of the company’s board of directors.
Gorsky has served as chairman and CEO of Johnson & Johnson since 2012. During his tenure, Gorsky has overseen a more than 60% increase in R&D investments to $12 billion in 2020, as well as hundreds of acquisitions and partnerships that contributed to the company’s growth across its three segments.
J&J noted that Gorsky has also led the company in transforming its Medical Devices business with a focus on electrophysiology, surgery, orthopaedics, vision care, and robotic and digital surgery, as well as shaping the Consumer Health portfolio with its strongholds in Self Care and Skin Health and foundation in Essential Health.
Duato has worked for more than 30 years at Johnson & Johnson, spanning multiple business sectors, geographies and functions. As Vice Chairman of the Executive Committee, he provides strategic direction for the Pharmaceutical and Consumer Health sectors and oversees the Global Supply Chain, Technology and Health & Wellness teams.